Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2019

Jul 13, 2019

30583_dirs_2019-07-12_d201a04a-9896-4a03-bf9a-e4484ad6f014.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-06-11

Reporting Person: MEIER RICHARD A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-11 Common Stock G 6000 Disposed 80040 Direct

Footnotes

F1: This transaction involved gifts of securities by the reporting person to irrevocable trusts for the benefit of the reporting person's children and for which the reporting person is not the trustee. The reporting person disclaims beneficial ownership of the shares held by such irrevocable trusts, and this report should not be deemed an admission that the reporting person is the beneficial owner of such shares.